跳至主要内容
临床试验/KCT0003834
KCT0003834招募中未知

Prospective comparison of histologic outcomes between 22G and 25G acquire FNA needle for pancreatic/peripancreatic mass

Asan Medical Center0 个研究点目标入组 140 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 79(Year)(—)
性别
All

入选标准

  • 1. Patients older than 18 years and younger than 80 years
  • 2. Patients with solid pancreatic/peripancreatic mass which is needed pathologic confirmation

排除标准

  • 1. cystic pancreatic lesions without the evidence of solid component suspected with malignant transformation
  • 2. cardiopulmonary instability
  • 3. severe coagulopathy (international normalized ratio > 1.5 or platelet count < 50,000 cells/cubic millimeter [cmm3])
  • 4. inability to suspend antithrombotic therapy
  • 5. pregnancy
  • 6. Patients with underlying co-morbidities preclude sedation
  • 7. GI obstruction or previous stomach surgery that preclude EUS examination
  • 8. refusal to provide informed consent or participate in the study.

研究者

相似试验